Skip to Content

Zytiga Sales Data

Rank 74 Current sales rank, all
U.S. Pharmaceuticals.

Last updated: February 2014 (updated quarterly).
The following data shows Zytiga U.S. retail sales in Q4 2013 compared to previous quarters.

Date Range Sales Rank Sales ($000) Units (000)
Q4 2013 74 (12) 11.86% 5.88%
Q3 2013 86 (2) 2.89%
Q2 2013 84 ()

* Units refer to the number of packages sold.

Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.

Related News

May 26, 2011New Drug Extends Survival for Men With Advanced Prostate Cancer
May 16, 2011New Drug Extends Life a Bit in Advanced Prostate Cancer
April 29, 2011Zytiga Approved for Advanced Prostate Cancer